semaglutide diabetes type 2 Oral Lowers HbA1c in Phase 3 Trial in Youth With Semaglutide ⏺Type 2 diabetes mellitus

Foundayo (orforglipron), another oral GLP-1 innovation, grants flexibility without the need for food or water restrictions

However, if treatment is stopped, most patients experience weight regain, underscoring obesitys nature as a chronic disease requiring persistent management

The compound works by suppressing appetite, improving insulin sensitivity, and increasing thermogenesis (heat production), which together create a powerful metabolic effect

Spirulina platensis ameliorates arsenic-mediated uterine damage and ovarian steroidogenic disorder

Target Market: Nigeria (Lagos, Abuja, Port Harcourt & Nationwide)

This creates a two-tier system where only patients with diabetes or cardiovascular comorbidities access these medications through traditional channels